Penn Bioengineers Show Why Lab-made Stem Cells Might Fail: Errors in DNA Folding – Penn: Office of University Communications
Penn: Office of University Communications |
Penn Bioengineers Show Why Lab-made Stem Cells Might Fail: Errors in DNA Folding
Penn: Office of University Communications Induced pluripotent stem cells hold promise for regenerative medicine because they can, in theory, turn into any type of tissue and because they are made from a patient’s own adult cells, guaranteeing compatibility. However, the technique that turns … |
Globes |
Israeli stem cell co Pluristem receives $3.3m grant
Globes The grant will support clinical trials and R&D activities in 2016 for the Haifa-based stem cell developer. Pluristem chairman and CEO Zami Aberman said, “The continued backing of the Israeli Innovation Authority is a vote of confidence in Pluristem … |
|
Mesenchymal Stem Cells Market – Latest Innovations, Drivers, Restraints, Challenges and Key Events in the industry …
Medgadget.com (blog) Logo111 Mesenchymal stem cells are the adult stem cells. Mesenchymal stem cells are of various types such as monocytes, adipocytes, osteocytes and chondrocytes. Mesenchymal stem cells main function is to replace or repair damage tissue. In addition … |
|
Cynata and apceth in deal to develop stem cell-based therapeutics
The Pharma Letter (registration) Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has entered into a worldwide license option agreement with German biopharma firm apceth. The agreement will combine Cynata’s Cymerus technology with genetic … |